Aquestive Therapeutics, Inc
Price
FilingsNewest: 8-K, Director or officer changeSep 29 →InsidersNo open-market buys. 9 insiders sold $2.6M, 6 of 13 sales on a 10b5-1 plan.→HoldersBratton 7.8%BlackRock 6.4%RTW Investments 5.9%→Financing →PeersClosest companies: AXSM, CGEM, XERS→
From the filings
Figures
- Revenue
- $54.1Mlast 12 months
- Net income
- −$78.2Mlast 12 months
- Operating cash flow
- −$43.8Mlast 12 months
- Cash and equivalents
- $98.5Mat the last balance sheet
- Total debt
- $55.0Mat the last balance sheet
- Shares outstanding
- 125.5M shareson issue